
THE UNSTABLE HEMOGLOBINS:
SOME GENETIC ASPECTS
Wajcman H1,*, Galacteros F2 *Corresponding Author: Dr. Henri Wajcman, INSERM U 468 and Service de Biochimie, Hôpital Henri Mondor AP-HP, 51 Avenue du Maréchal de Lattre de Tassigny, 94010 Créteil, France page: 3
|
HYPERUNSTABLE HEMOGLOBIN VARIANTS
These variants are also named dominant β-thalassemias, which suggests that they cannot usually be detected in peripheral blood.. They result from a large variety of mutations leading to a protein which is destroyed in the minutes or hours following its biosynthesis [29-34]. Some are due to point mutations in regions crucial for the assembly of the Hb tetramer, or to frameshift mutations leading to globin chains that cannot associate in functional tetramers. The pathophysiology of this group of variants associates with an unstable β chain, which precipitates within the erythroid precursors, to an excess of free α chains, which are highly unstable molecules (Fig. 2). Thus, the resulting phenotype is close to that of thalassemia intermedia, in which the pathological manifestations result from the presence of these α chains, which, by precipitating in the erythroid precursors, catalyze the formation of reactive oxygen species toxic for the membranes, leading thus to cell apoptosis and ineffective erythropoiesis. Hyperunstable Hb variants are suspected when α thalassemia intermedia phenotype is observed in a patient belonging to α population where thalassemic mutations are rare or absent. In these cases de novo mutations are also frequent. A problem of diagnosis exists in regions where thalassemias are frequent: in these populations, thalassemia intermedia usually results from a compound heterozygous state involving two β thalassemia alleles, or the effect of an α chain triplication on a β-thal allele. A compound heterozygous state for a β+-thal and a mildly unstable Hb variant is also possible. In the case of an hyperunstable Hb, any of the thalassemic mutations present in the ethnic group of the patient, could be found. Since these Hbs are usually not detected by electrophoretic or chromatographic methods, molecular biology studies have to be performed. After polymerase chain reaction (PCR) amplification of the β gene a conformational analysis [denaturing gradient gel electrophoresis (DGGE), single strand conformation polymorphism (SSCP) or denaturing high performance liquid chromatography (HPLC)] may show the presence of an abnormal allele. The β gene almost always needs to be sequenced, since a specific probe is usually not available, or only when there is a reason to suspect some specific mutation. Hyperunstable Hbs are, in fact, a very rare cause of thalassemia intermedia. They may be distinguished from true thalassemic alleles by biosynthetic studies performed after various times of incubation. In these variants, globin chain biosynthesis is balanced at very short times of incubation and can become unbalanced, thalassemia-like, at longer times. When several members of a family are affected they all display an identical thalassemia intermedia dominant phenotype.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|